CytoTools AG-Product Pipeline Review-2015

CytoTools AG-Product Pipeline Review-2015

  • Products Id :- GMDHC07465CDB
  • |
  • Pages: 29
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

CytoTools AG-Product Pipeline Review-2015


Global Markets Direct's, 'CytoTools AG-Product Pipeline Review-2015', provides an overview of the CytoTools AG's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of CytoTools AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of CytoTools AG including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of CytoTools AG's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the CytoTools AG's pipeline products

Reasons To Buy

Evaluate CytoTools AG's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of CytoTools AG in its therapy areas of focus

Identify new drug targets and therapeutic classes in the CytoTools AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of CytoTools AG and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of CytoTools AG

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of CytoTools AG and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

CytoTools AG Snapshot 5

CytoTools AG Overview 5

Key Information 5

Key Facts 5

CytoTools AG-Research and Development Overview 6

Key Therapeutic Areas 6

CytoTools AG-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

CytoTools AG-Pipeline Products Glance 10

CytoTools AG-Late Stage Pipeline Products 10

Pre-Registration Products/Combination Treatment Modalities 10

Phase III Products/Combination Treatment Modalities 11

CytoTools AG-Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

CytoTools AG-Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

CytoTools AG-Drug Profiles 16

CL-05 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

PEP-04 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

HMW-02Ak 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

HMW-02Ap 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

LMW-0X 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

CytoTools AG-Pipeline Analysis 22

CytoTools AG-Pipeline Products by Route of Administration 22

CytoTools AG-Pipeline Products by Molecule Type 23

CytoTools AG-Recent Pipeline Updates 24

CytoTools AG-Dormant Projects 26

CytoTools AG-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Appendix 28

Methodology 28

Coverage 28

Secondary Research 28

Primary Research 28

Expert Panel Validation 28

Contact Us 28

Disclaimer 29

List of Tables

CytoTools AG, Key Information 5

CytoTools AG, Key Facts 5

CytoTools AG-Pipeline by Indication, 2015 7

CytoTools AG-Pipeline by Stage of Development, 2015 8

CytoTools AG-Monotherapy Products in Pipeline, 2015 9

CytoTools AG-Pre-Registration, 2015 10

CytoTools AG-Phase III, 2015 11

CytoTools AG-Phase II, 2015 12

CytoTools AG-Phase I, 2015 13

CytoTools AG-Preclinical, 2015 14

CytoTools AG-Discovery, 2015 15

CytoTools AG-Pipeline by Route of Administration, 2015 22

CytoTools AG-Pipeline by Molecule Type, 2015 23

CytoTools AG-Recent Pipeline Updates, 2015 24

CytoTools AG-Dormant Developmental Projects,2015 26

CytoTools AG, Subsidiaries 27

List of Figures

CytoTools AG-Pipeline by Top 10 Indication, 2015 7

CytoTools AG-Pipeline by Stage of Development, 2015 8

CytoTools AG-Monotherapy Products in Pipeline, 2015 9

CytoTools AG-Pipeline by Top 10 Route of Administration, 2015 22

CytoTools AG-Pipeline by Top 10 Molecule Type, 2015 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Current R&D Portfolio of CytoTools AG; CytoTools AG - Key Therapeutics; CytoTools AG - Pipeline Overview and Promising Molecules; CytoTools AG - News; CytoTools AG - Latest Updates; CytoTools AG - Pipeline; CytoTools AG - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 102105
Site License
USD 3000 INR 204210
Corporate User License
USD 4500 INR 306315



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]